Velabs Therapeutics' Spinoff / Spinout Round

Velabs Therapeutics raised a round of funding on January 01, 2017. Investors include European Molecular Biology Laboratory.

Velabs Therapeutics specializes in microfluidics-based screening technology and applications. The company's droplet-based microfluidic screening technology aims at the fast generation of antibodies ag…

Articles about Velabs Therapeutics' Spinoff / Spinout Round: